• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Tetra: Venture Capital Funding History

Tetra

To add a bio or update company history click update information.

News from Tetra

    Tetra secures a £450k pre-seed round from angels for surgical scheduling software for hospitalsTetra secures a £450k pre-seed round from angels for surgical scheduling software for hospitals
    Tetra
    26 Feb 2026

    Tetra secures a £450k pre-seed round from angels for surgical scheduling software for hospitals

    Tetra builds surgical scheduling software for hospitals. Its platform helps NHS theatre teams plan and manage elective care more accurately using data modelling and forecasting.

Tetra
  • Health
  • London, United Kingdom
  • £450k
  • tetratech.uk
  • Update Information

More venture news

  • Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
    Inovus Medical
    30 Sept 2026

    Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training

    EquityHealth
  • DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
    DYAD
    29 Sept 2026

    DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records

    Series AHealth
  • IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
    IMS Solutions
    24 Sept 2026

    IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS

    SeedHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn